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Conclusion
•  It is unclear whether APS may 
predispose a patient to HIT. The 
concurrence of both disease 
processes is possible and should  
be considered in patients with 
either diagnosis who are not 
improving with treatment.
•  The presence of severe 
thrombocytopenia in CAPS is  
not common and should raise  
the suspicion for HIT.
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Discussion
•  CAPS and HIT are rare thrombotic disorders 
with high risk for morbidity and mortality.
•		It	is	estimated	that	CAPS	affects	1%	of	





•  Both disease processes are driven by 
autoantibodies and it is possible that this 
pathogenic similarity may create a rare 
overlapping presentation.
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•  64-year-old female with history of APS 
on coumadin and remote ischemic 
stroke secondary to APS presented 
with worsening encephalopathy.
•  On recent prior hospitalization, coumadin 
was held because of traumatic SAH 
and SDH. Coumadin was re-started 
one week later by neurosurgery after 
CT showed near resolution.
•  Initial workup was negative for new 
intracranial bleeds, but CT abdomen/
pelvis demonstrated bilateral adrenal 
hemorrhages. Labs showed worsening 
AKI and elevated transaminases.
•		These	findings	indicated	probable	
CAPS (3 of 4 criteria) and she was 
subsequently started on plasma 
exchange.
•  Anticoagulation was initially held in the 
setting of her adrenal hemorrhages. 
Heparin drip was later started on day  
four of the hospitalization. 
•  Because of persistent thrombocytopenia 
and	prior	exposure	to	subcutaneous	
heparin, HAPA was sent and resulted 
positive. SRA was also positive, 
confirming	HIT.	Heparin	drip	was	
switched to argatroban.
•  Subsequent brain MRI noted numerous 
acute to subacute infarctions throughout 
both the cerebral and cerebellar 
hemispheres consistent with embolic 
phenomenon. The etiology of these 
emboli was not discovered. The patient 
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